9th Advances in Colorectal Oncology: Controversies and Emerging Approaches

This two-day live symposium at Memorial Sloan Kettering Cancer Center will focus on the surgical and multidisciplinary management of colorectal cancer. National and international leaders in surgery, medical oncology, and radiation oncology will address current controversies and highlight emerging approaches in the treatment of both localized and metastatic disease.

Highlights of this year's program include:

• Live surgery presentations streamed directly from MSK’s operating rooms

• Focused sessions exploring current controversies in the medical and surgical management of rectal cancer, with a focus on TNT and Watch-and-Wait approaches

• Cutting edge updates in the treatment of colorectal malignancies, including advances in KRAS and BRAF targeted therapies

• Reviews of recent clinical trials in colon, rectal, and anal cancers

• Interactive multidisciplinary tumor boards featuring complex case discussions

• Networking opportunities to connect with leading experts and peers

This comprehensive program is designed to equip participants with the latest evidence-based strategies and multidisciplinary perspectives that are shaping the future of colorectal cancer care—ultimately advancing clinical practice and improving patient outcomes.

Target Audience: This symposium is intended for medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists, and other oncology care team members interested in rectal cancer. A virtual attendance option is available for those unable to join us in New York City.

Post-Symposium Resources: All registered participants will also receive access to an online syllabus following the symposium, which will include presentation recordings and faculty slide decks in PDF format.

1. Describe the requirements for a successful, multidisciplinary colorectal cancer program
2. Discuss technical options for the surgical management of distal rectal cancer
3. Identify appropriate candidates for Watch and Wait and adjuncts to optimize organ preservation
4. Discuss evidence-based practice recommendation for the management of metastatic colorectal cancer
5. Review advancements in immunotherapy and alternative strategies for managing colorectal cancer

This symposium offers the option to attend either in person or virtually. Attendance type should be selected during registration.

Registration Rates

• Physicians (MDs, PhDs, DOs): $400

• Advanced Practice Providers: $350

• Residents, Fellows, and Other Healthcare Providers: $300

• Industry Professionals*: $950

• MSK Employees: Complimentary

*An “industry professional” is defined as any individual—regardless of profession (e.g., MD, PhD, APP, RN)—who is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Meals and Accommodations: Continental breakfast, lunch, and refreshment breaks will be provided to in-person participants. If you have dietary restrictions or require special accommodations to attend in person, please contact us at [email protected] at least one week prior to the course.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 15.25 Medical Knowledge MOC Points in the American Board of Internal Medicine's Maintenance (ABIM) of Certification Assessment Recognition program; and

• 15.25 Accredited CME and Self-Assessment MOC points in the American Board of Surgery’s (ABS) Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.

ANCC CNE Statement

Contact hours pending application approval.

We look forward to welcoming you to Memorial Sloan Kettering Cancer Center (MSK).

If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, MSK has negotiated special rates and amenities at select hotels in Manhattan. Click here to view the list of select hotels and additional details on each.

For details on planning your visit to MSK, including travel and parking information, click here. Please note that parking validation is not available for attendees.

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

Julio Garcia-Aguilar, MD, PhD
Chief, Colorectal Service
Benno C. Schmidt Chair in Surgical Oncology
Department of Surgery 

Andrea Cercek, MD
Attending, Gastrointestinal Oncology Service
Section Head, Colorectal Cancer
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers
Department of Medicine

Garrett M. Nash, MD, MPH, FACS, FASCRS
Attending, Colorectal Service
Vice President of Quality and Safety
Department of Surgery

Paul Romesser, MD
Assistant Attending
Director of Colorectal and Anal Cancer
Department of Radiation Oncology

Maria Widmar, MD, MPH
Assistant Attending, Colorectal Service
Department of Surgery  

Rona Yaeger, MD
Attending, Gastrointestinal Oncology Service
Department of Medicine 

MSK Symposium Planners

Jin Kim, MD
Colorectal Surgery Fellow

Rachel Rassam, NP
Adult Care Nurse Practitioner

Guest Faculty 

Geerard Beets, MD 
Professor, Department of Surgery
The Netherlands Cancer Institute

Andrew T. Chan, MD, MPH
Chief, Clinical and Translational Epidemiology Unit
Massachusetts General Hospital

Alessandro Fichera, MD
Chief, Division of Colon and Rectal Surgery
NewYork-Presbyterian, Weill Cornell Medicine

Guodong He, MD, PhD
Colorectal Surgeon
Zhongshan Hospital, Fudan University

Scott Kopetz, MD, PhD, FACP
Deputy Chair for Translational Research,
Department of Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center

Sheela Rao, MBBS, MD, FRCP
Consultant Medical Oncologist, Gastrointestinal Unity
Royal Marsden Hospital

Anwaar Saeed, MD
Chief, Gastrointestinal Medical Oncology Program
University of Pittsburgh School of Medicine

Kai-Keen Shiu, FRCP, PhD
Medical Oncology Consultant, Gastrointestinal Oncology Service;
UCLH Clinical Lead, Cancer of Unknown Primary and Acute Oncology
HCA Healthcare UK
Associate Professor, UCL Cancer Institute

Patricia Sylla, MD, FACS, FASCRS
System Chief, Colon and Rectal Surgery
Mount Sinai Health System

Jurriaan Tuynman, MD, PhD
Professor, Surgery
Amsterdam UMC 

MSK Faculty 

Mohammad Ali Abbass, MD, MPH
Assistant Attending, Colorectal Service,
Department of Surgery

Vinod P. Balachandran, MD
Assistant Attending, Hepatopancreatobiliary Service,
Department of Surgery

Christopher Crane, MD
Attending, Department of Radiation Oncology

Luis Diaz Jr., MD
Division Head, Solid Tumor Oncology;
Attending, Gastrointestinal Oncology Service, 
Department of Medicine

Imane El Dika, MD
Assistant Attending, Gastrointestinal Oncology Service, 
Department of Medicine 

Michael Foote, MD
Assistant Attending, Gastrointestinal Oncology Service, 
Department of Medicine 

Karuna Ganesh, MD, PhD
Assistant Attending, Gastrointestinal Oncology Service, 
Department of Medicine 

Marc J. Gollub, MD, FACR
Director, Colorectal Radiology; 
Attending Radiologist, Body Imaging Service, 
Department of Radiology

Georgios Karagkounis, MD
Assistant Attending, Colorectal Service,
Department of Surgery 

Maliha Nusrat, MD, MS
Assistant Attending, Gastrointestinal Oncology Service, 
Department of Medicine

Emmanouil P. Pappou, MD, PhD, FACS, FASCRS
Assistant Attending, Colorectal Service,
Department of Surgery

Philip B. Paty, MD
Attending, Colorectal Service,
Department of Surgery

Leonard Saltz, MD
Head, Colorectal Oncology Section; 
Attending, Gastrointestinal Oncology Service, 
Department of Medicine

Jessica Scott, PhD
Head, Exercise Oncology Program and Principal Investigator

Deb Schrag, MD, MPH
Chair, Department of Medicine

Neil H. Segal, MD, PhD
Research Director, Division of Gastrointestinal Oncology; 
Associate Attending, Gastrointestinal Oncology Service, 
Department of Medicine

Jinru Shia, MD
Director, Gastrointestinal Pathology;
Attending, Department of Pathology and Laboratory Medicine

Iris H. Wei, MD, FACS
Assistant Attending, Colorectal Service
Department of Surgery 

Martin R. Weiser, MD
Acting Chair, Department of Surgery; 
Stuart H.Q. Quan Chair in Colorectal Surgery; 
Attending, Colorectal Service, Department of Surgery

Abraham J. Wu, MD
Attending, Department of Radiation Oncology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.